Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Spring 2016 - Safety
Download Issue
Share
Up Front
Publisher's Corner
Patient Safety Is a Collective Responsibility
By Patrick M. Schmidt
Features
Blood Protein Therapeutics: It All Starts with the Plasma
By
Keith Berman, MPH, MBA
Myths and Facts: Venomous Snakebites
By
Ronale Tucker Rhodes, MS
Narrative Medicine: How Stories of Illness Affect Caregiving
By
BSTQ Staff
Hope for Hepatitis C
By
Meredith Whitmore
Zoonotic Diseases: An Emerging Global Health Challenge
By
Trudie Mitschang
Irreproducible Research: The Need for Study Validation
By
Jim Trageser
BioTrends Watch
Washington Report
Current CMS Biosimilars Reimbursement Policy Outlined
CMS Creates Site that Lists Drug Use and Spending
HHS Announces More Funding to Improve Healthcare
Reimbursement FAQs
Data Collection: A New Regime
Industry News
New Gene Therapy Could Be Safe, Effective for Hemophilia B Patients
2015-16 Flu Vaccine Is Nearly 60 Percent Effective
FDA Approves Keytruda to Treat Lung Cancer
Newly Approved Drug Reverses Effects of Neuromuscular Blocking Drugs Used During Surgery
ProMetic Completes First Dosing in Plasminogen Deficiency Patients
Biomarker Found in CIDP Patients Who Don't Respond to IVIG Therapy
FDA Approves Adynovate to Treat Hemophilia A
Engineered Protein Controls Bleeding in Severe VWD
FDA Issues Guidance to Protect Blood Supply from Zika Virus
New Type of Sound Wave May Allow for Inhalable Vaccines
Cancer-Causing Gene Found in Plasma May Help Predict Outcomes for Patients
FDA Approves Boosted Flu Vaccine for Older Adults
BioFocus
Industry Insight
The New Therapeutic Renaissance for Patients with Rare Bleeding Disorders
By Keith Berman, MPH, MBA
Patient Profile
Polio: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Polio: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Single IVIG Infusion Associated with Improved Recovery and Histopathological Profile in Rat Model of Ischemic Stroke
Inhaled Alpha-1 Proteinase Inhibitor Safe, Well-Tolerated and Effective in Raising Sputum Levels in Patients with Cystic Fibrosis